To study benefits of Azithromycin in children suffering from bronchiectasis.
Phase 3
- Conditions
- Health Condition 1: J479- Bronchiectasis, uncomplicated
- Registration Number
- CTRI/2020/11/029441
- Lead Sponsor
- AIIMS Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Children aged 1-18 years with non-Cystic Fibrosis bronchiectasis with at least 1 pulmonary exacerbation in last 12 months.
2. Normal sweat chloride levels.
Exclusion Criteria
1. Known/ suspected immune deficiency or immune dysregulation.
2. On long term azithromycin therapy ( > 2 week).
3. Known allergy to macrolides
4. Known underlying chronic liver or renal disease.
5. Regular follow up not possible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method